- Home
- Who we are
- Read, watch, listen
- Pharmacy
- Home Delivery
- Specialty Pharmacy
- Specialty Pharmacy - Patients
- Care Specialists Program
- Education Center
- Hypercholesterolemia
- Solid organ transplant
- Asthma
- Cystic fibrosis
- Hemophilia
- Hepatitis C
- Human Immunodeficiency Virus (HIV)
- Inflammatory bowel disease
- Osteoporosis
- Multiple Sclerosis
- Oncology (cancer)
- Psoriasis and psoriatic arthritis
- Rheumatoid arthritis
- Rights and responsibilities
- Overcome medicine challenges
- Specialty Pharmacy - Providers
- Patient Forms
- Careers
- Benefits
- Hub + Home
- Medication Therapy Management Internship
- Managed Care Residency Program
- Application Process
- Contact Us
- News & Insights
- Events
- In the news
- Perspectives
- Press releases
- Research & publications
- Cell & Gene Pipeline Outlook
- Clinical Insights
- 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
- 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
- Summer 2025 Issue: Clinical Insights – MASH
- Drug Approvals
- Drug Approvals Monthly Update: January 2024
- Drug Approvals Quarterly Update: January 2024
- Drug Approvals Monthly Update: February 2024
- Drug Approvals Monthly Update: April 2024
- Drug Approvals Quarterly Update: April 2024
- Drug Approvals Monthly Update: March 2024
- Drug Approvals Monthly Update: May 2024
- Drug Approvals Monthly Update: June 2024
- Drug Approvals: July 2024
- Drug Approvals Monthly Update: August 2024
- Drug Approvals Monthly Update: September 2024
- Drug Approvals: October 2024
- Drug Approvals: November 2024
- Drug Approvals: December 2024
- Drug Approvals: January 2025
- Drug Approvals: February 2025
- Drug Approvals: March 2025
- Drug Approvals: April 2025
- FDA Decisions Expected
- 2024-2025
- FDA Decisions Expected: October 2024
- FDA Decisions Expected November 2024
- FDA Decisions Expected: December 2024
- FDA Decisions Expected: January 2025
- FDA Decisions Expected: February 2025
- FDA Decisions Expected: March 2025
- FDA Decisions Expected: April 2025
- FDA Decisions Expected: May 2025
- FDA Decisions Expected: June 2025
- FDA Decisions Expected: July 2025
- FDA Decisions Expected: August 2025
- FDA Decisions Expected: September2025
- FDA Decisions Expected: October 2025
- FDA Decisions Expected: November 2025
- FDA Decisions Expected: December 2025
- FDA Decisions Expected: January 2026
- FDA Decisions Expected: February 2026
- FDA Decisions Expected: March 2026
- FDA Decisions Expected: April 2026
- FDA Decisions Expected: May 2026
- FDA Decisions Expected: June 2026
- FDA Decisions Expected: July 2026
- FDA Decisions Expected: August 2026
- FDA Decisions Expected: September 2026
- FDA Decisions Expected: October 2026
- GLP-1 Pipeline Update
- 2024-2025
- GLP-1 Pipeline Update: November 2024
- GLP-1 Pipeline Update: November 2025
- The evolution of GLP-1s
- GLP-1 Pipeline Update: February 2025
- GLP-1 Pipeline Update: May 2025
- GLP-1 Pipeline Update: August 2025
- GLP-1 Pipeline Update: February 2026
- GLP-1 Pipeline Update: May 2026
- GLP-1 Pipeline Update: August 2026
- Medicaid Trend Report
- Medical Pharmacy Trend Report
- 2024 Medical Pharmacy Trend Report
- 2025 Medical Pharmacy Trend Report
- 2026 Medical Pharmacy Trend Report Part 1
- 2026 Medical Pharmacy Trend Report Part 2
- 2026 Medical Pharmacy Trend Report
- Oncology Insights
- 2024-2025
- Oncology Insights: Transformative treatment for small cell lung cancer
- Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
- Oncology Insights: October 2024
- Oncology Insights: December 2024
- Oncology Insights: 2024 Rewind
- Oncology Insights: February 2025
- Oncology Insights: March 2025
- Oncology Insights: April 2025
- Oncology Insights: May 2025
- Oncology Insights: June 2025
- Oncology Insights: July 2025
- Oncology Insights: August 2025
- Oncology Insights: September 2025
- Oncology Insights: October 2025
- Oncology Insights: November 2025
- Oncology Insights: December 2025
- Oncology Insights: January 2026
- Oncology Insights: February 2026
- Oncology Insights: March 2026
- Oncology Insights: April 2026
- Oncology Insights: May 2026
- Oncology Insights: June 2026
- Oncology Insights: July 2026
- Oncology Insights: August 2026
- Oncology Insights: September 2026
- Prime Therapeutics Report
- Fall 2024 Prime Therapeutics Report
- Spring 2024 Prime Therapeutics Report
- Summer 2024 Prime Therapeutics Report
- Spring 2025 Prime Therapeutics Report
- Summer 2025 Prime Therapeutics Report
- Fall 2025 Prime Therapeutics Report
- Spring 2026 Prime Therapeutics Report
- Summer 2026 Prime Therapeutics Report
- Quarterly Drug Pipeline
- 2024-2025
- Quarterly Drug Pipeline Template 2.0
- Quarterly Drug Pipeline: January 2024
- Quarterly Drug Pipeline: April 2024
- Quarterly Drug Pipeline: July 2024
- Quarterly Drug Pipeline: October 2024
- Quarterly Drug Pipeline: January 2025
- Quarterly Drug Pipeline: April 2025
- Quarterly Drug Pipeline: July 2025
- Quarterly Drug Pipeline: October 2025
- Quarterly Drug Pipeline: January 2026
- Quarterly Drug Pipeline: April 2026
- Quarterly Drug Pipeline: July 2026
- Research posters & abstracts
- Trending Topics & Drug Approvals
- 2024-2025
- Trending Topics & Drug Approvals: May 2025
- Trending Topics & Drug Approvals: June 2025
- Trending Topics & Drug Approvals: July 2025
- Trending Topics & Drug Approvals: August 2025
- Trending Topics & Drug Approvals: September 2025
- Trending Topics & Drug Approvals: November 2025
- Trending Topics & Drug Approvals: December 2025
- Trending Topics & Drug Approvals: January 2026
- Trending Topics & Drug Approvals: February 2026
- Trending Topics & Drug Approvals: March 2026
- Trending Topics & Drug Approvals: April 2026
- Trending Topics & Drug Approvals: May 2026
- Trending Topics & Drug Approvals: June 2026
- Trending Topics & Drug Approvals: July 2026
- Trending Topics & Drug Approvals: August 2026
- White papers
- Stories
- Compliance / Legal
- Home
- Who we are
- Read, watch, listen
- Pharmacy
- Home Delivery
- Specialty Pharmacy
- Specialty Pharmacy - Patients
- Care Specialists Program
- Education Center
- Hypercholesterolemia
- Solid organ transplant
- Asthma
- Cystic fibrosis
- Hemophilia
- Hepatitis C
- Human Immunodeficiency Virus (HIV)
- Inflammatory bowel disease
- Osteoporosis
- Multiple Sclerosis
- Oncology (cancer)
- Psoriasis and psoriatic arthritis
- Rheumatoid arthritis
- Rights and responsibilities
- Overcome medicine challenges
- Specialty Pharmacy - Providers
- Patient Forms
- Careers
- Benefits
- Hub + Home
- Medication Therapy Management Internship
- Managed Care Residency Program
- Application Process
- Contact Us
- News & Insights
- Events
- In the news
- Perspectives
- Press releases
- Research & publications
- Cell & Gene Pipeline Outlook
- Clinical Insights
- 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
- 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
- Summer 2025 Issue: Clinical Insights – MASH
- Drug Approvals
- Drug Approvals Monthly Update: January 2024
- Drug Approvals Quarterly Update: January 2024
- Drug Approvals Monthly Update: February 2024
- Drug Approvals Monthly Update: April 2024
- Drug Approvals Quarterly Update: April 2024
- Drug Approvals Monthly Update: March 2024
- Drug Approvals Monthly Update: May 2024
- Drug Approvals Monthly Update: June 2024
- Drug Approvals: July 2024
- Drug Approvals Monthly Update: August 2024
- Drug Approvals Monthly Update: September 2024
- Drug Approvals: October 2024
- Drug Approvals: November 2024
- Drug Approvals: December 2024
- Drug Approvals: January 2025
- Drug Approvals: February 2025
- Drug Approvals: March 2025
- Drug Approvals: April 2025
- FDA Decisions Expected
- 2024-2025
- FDA Decisions Expected: October 2024
- FDA Decisions Expected November 2024
- FDA Decisions Expected: December 2024
- FDA Decisions Expected: January 2025
- FDA Decisions Expected: February 2025
- FDA Decisions Expected: March 2025
- FDA Decisions Expected: April 2025
- FDA Decisions Expected: May 2025
- FDA Decisions Expected: June 2025
- FDA Decisions Expected: July 2025
- FDA Decisions Expected: August 2025
- FDA Decisions Expected: September2025
- FDA Decisions Expected: October 2025
- FDA Decisions Expected: November 2025
- FDA Decisions Expected: December 2025
- FDA Decisions Expected: January 2026
- FDA Decisions Expected: February 2026
- FDA Decisions Expected: March 2026
- FDA Decisions Expected: April 2026
- FDA Decisions Expected: May 2026
- FDA Decisions Expected: June 2026
- FDA Decisions Expected: July 2026
- FDA Decisions Expected: August 2026
- FDA Decisions Expected: September 2026
- FDA Decisions Expected: October 2026
- GLP-1 Pipeline Update
- 2024-2025
- GLP-1 Pipeline Update: November 2024
- GLP-1 Pipeline Update: November 2025
- The evolution of GLP-1s
- GLP-1 Pipeline Update: February 2025
- GLP-1 Pipeline Update: May 2025
- GLP-1 Pipeline Update: August 2025
- GLP-1 Pipeline Update: February 2026
- GLP-1 Pipeline Update: May 2026
- GLP-1 Pipeline Update: August 2026
- Medicaid Trend Report
- Medical Pharmacy Trend Report
- 2024 Medical Pharmacy Trend Report
- 2025 Medical Pharmacy Trend Report
- 2026 Medical Pharmacy Trend Report Part 1
- 2026 Medical Pharmacy Trend Report Part 2
- 2026 Medical Pharmacy Trend Report
- Oncology Insights
- 2024-2025
- Oncology Insights: Transformative treatment for small cell lung cancer
- Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
- Oncology Insights: October 2024
- Oncology Insights: December 2024
- Oncology Insights: 2024 Rewind
- Oncology Insights: February 2025
- Oncology Insights: March 2025
- Oncology Insights: April 2025
- Oncology Insights: May 2025
- Oncology Insights: June 2025
- Oncology Insights: July 2025
- Oncology Insights: August 2025
- Oncology Insights: September 2025
- Oncology Insights: October 2025
- Oncology Insights: November 2025
- Oncology Insights: December 2025
- Oncology Insights: January 2026
- Oncology Insights: February 2026
- Oncology Insights: March 2026
- Oncology Insights: April 2026
- Oncology Insights: May 2026
- Oncology Insights: June 2026
- Oncology Insights: July 2026
- Oncology Insights: August 2026
- Oncology Insights: September 2026
- Prime Therapeutics Report
- Fall 2024 Prime Therapeutics Report
- Spring 2024 Prime Therapeutics Report
- Summer 2024 Prime Therapeutics Report
- Spring 2025 Prime Therapeutics Report
- Summer 2025 Prime Therapeutics Report
- Fall 2025 Prime Therapeutics Report
- Spring 2026 Prime Therapeutics Report
- Summer 2026 Prime Therapeutics Report
- Quarterly Drug Pipeline
- 2024-2025
- Quarterly Drug Pipeline Template 2.0
- Quarterly Drug Pipeline: January 2024
- Quarterly Drug Pipeline: April 2024
- Quarterly Drug Pipeline: July 2024
- Quarterly Drug Pipeline: October 2024
- Quarterly Drug Pipeline: January 2025
- Quarterly Drug Pipeline: April 2025
- Quarterly Drug Pipeline: July 2025
- Quarterly Drug Pipeline: October 2025
- Quarterly Drug Pipeline: January 2026
- Quarterly Drug Pipeline: April 2026
- Quarterly Drug Pipeline: July 2026
- Research posters & abstracts
- Trending Topics & Drug Approvals
- 2024-2025
- Trending Topics & Drug Approvals: May 2025
- Trending Topics & Drug Approvals: June 2025
- Trending Topics & Drug Approvals: July 2025
- Trending Topics & Drug Approvals: August 2025
- Trending Topics & Drug Approvals: September 2025
- Trending Topics & Drug Approvals: November 2025
- Trending Topics & Drug Approvals: December 2025
- Trending Topics & Drug Approvals: January 2026
- Trending Topics & Drug Approvals: February 2026
- Trending Topics & Drug Approvals: March 2026
- Trending Topics & Drug Approvals: April 2026
- Trending Topics & Drug Approvals: May 2026
- Trending Topics & Drug Approvals: June 2026
- Trending Topics & Drug Approvals: July 2026
- Trending Topics & Drug Approvals: August 2026
- White papers
- Stories
- Compliance / Legal
Improve medication therapy management
Our boundary-pushing clinical solutions target the whole care continuum and deliver the best experience for you and your members.
Improve safety, reduce waste with MTM
Our integrated Medication Therapy Management (MTM) program supports adherence and appropriate drug use. We close gaps in care by engaging members and prescribers, helping to improve safety, decrease waste and connect the health care journey.
Identify opportunities
We use enhanced targeting to find ways to improve care through pharmacy, medical and lab data, customized analytics and expanded enrollment.
Engage and monitor
A pharmacist spends time with each member to encourage communication and collaboration between members and their health care professionals.
Deliver results
You get regular activity and outcomes reporting that’s focused on Stars and HEDIS measures, and we provide you with proven, published ROI.